These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36386869)

  • 1. Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation.
    Ellis GI; Deng MZ; Winn DW; Coker KE; Shukla D; Bhoj V; Milone MC; Duran-Struuck R; Riley JL
    STAR Protoc; 2022 Dec; 3(4):101784. PubMed ID: 36386869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque.
    Ellis GI; Coker KE; Winn DW; Deng MZ; Shukla D; Bhoj V; Milone MC; Wang W; Liu C; Naji A; Duran-Struuck R; Riley JL
    Cell Rep Med; 2022 May; 3(5):100614. PubMed ID: 35551746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of human CAR-NK cells with lentiviral vectors and functional assessment
    Portillo AL; Hogg R; Ashkar AA
    STAR Protoc; 2021 Dec; 2(4):100956. PubMed ID: 34825217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures.
    Selli ME; Landmann JH; Arveseth C; Singh N
    STAR Protoc; 2023 Mar; 4(1):101954. PubMed ID: 36607811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.
    Mohseni YR; Tung SL; Dudreuilh C; Lechler RI; Fruhwirth GO; Lombardi G
    Front Immunol; 2020; 11():1608. PubMed ID: 32793236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer.
    Rotolo A; Atherton MJ; Kasper BT; Haran KP; Mason NJ
    STAR Protoc; 2021 Dec; 2(4):100905. PubMed ID: 34746864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of hypoxia-sensing chimeric antigen receptor T cells.
    Kosti P; Larios-Martinez KI; Maher J; Arnold JN
    STAR Protoc; 2021 Sep; 2(3):100723. PubMed ID: 34401788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40L-stimulated B cells for ex-vivo expansion of polyspecific non-human primate regulatory T cells for translational studies.
    Alonso-Guallart P; Llore N; Lopes E; Kofman SB; Ho SH; Stern J; Pierre G; Bruestle K; Tang Q; Sykes M; Griesemer A
    Clin Exp Immunol; 2021 Mar; 203(3):480-492. PubMed ID: 33058141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol to generate traceable CAR T cells for syngeneic mouse cancer models.
    Zhang D; Krimitza E; Han K; Su R; Xu DJ; Xu JR; Gong Y; Fan Y
    STAR Protoc; 2024 Mar; 5(1):102898. PubMed ID: 38367235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for expansion and retroviral transduction of mouse regulatory T cells.
    Wu D; Wong MQ; Vent-Schmidt J; Boardman DA; Steiner TS; Levings MK
    J Immunol Methods; 2021 Jan; 488():112931. PubMed ID: 33221458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
    Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S
    Front Immunol; 2022; 13():874157. PubMed ID: 35720402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Fu RY; Chen AC; Lyle MJ; Chen CY; Liu CL; Miao CH
    Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
    De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
    Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
    Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
    J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and application of TGFβ-educated human Vγ9Vδ2 T cells.
    Parente-Pereira AC; Beatson RE; Davies DM; Hull C; Whilding LM; Porter JC; Maher J
    STAR Protoc; 2022 Jun; 3(2):101319. PubMed ID: 35496793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
    Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
    Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.